Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Year-over-year growth in CVS Health's (CVS) top line is aided by a strong Pharmacy Services segment, benefiting from the upside in specialty services.

CVS Health's (CVS) Q1 Earnings Top Estimates, EPS View Up

CVS Health Corporation (CVS) CEO Larry Merlo on Q1 2019 Results - Earnings Call Transcript

CVS Health Corp. released its first-quarter financial results before the markets opened on Wednesday.

How CVS Health Is Crushing It After Q1 Earnings

Apple

Apple and CVS Health pulled stock futures higher Wednesday as the Nasdaq looked for a rebound and markets awaited a Federal Reserve announcement.

Stock Futures Steer Higher As Apple and CVS Health received early earnings boosts

Shares of CVS Health Corp. CVS, +0.72% surged 4.5% in premarket trade Wednesday, after the drug store chain reported first-quarter profit, revenue and same-store sales that beat expectations, and lifted its full-year outlook.

CVS Health's stock surges after profit, revenue and same-store sales beat expectations

CVS Health on Wednesday reported results from its fiscal first quarter.

CVS Health beats first-quarter expectations, raises full-year forecast

Shares appear cheap on a fundamental and technical basis as CVS looks to show progress toward becoming a "health care hub."

CVS Stock Is 'Too Cheap to Ignore' Ahead of Earnings

Within Pharmacy Services, despite a fierce pricing competition, CVS Health (CVS) is currently riding on high level of service and execution, competitive pricing and a unique integrated model.

Will Pharmacy Services Drive CVS Health's (CVS) Q1 Earnings?

CVS Health will open "hundreds" of SmileDirectClub locations inside its stores this year, with plans to open more than 1,000 locations over the next two years, the drugstore chain announced Thursday.

CVS will bring hundreds of SmileDirectClub shops to its stores this year

Delta Air Lines

Winnebago

The market may be getting frothy, but these three stocks will help keep you grounded.

3 Rock Solid Cheap Stocks With P/E Ratios Under 11

Bristol-Myers

UnitedHealth Group

Walgreens

Now that I've recession proofed my portfolio, I'm continuing to diversify into the best "fat pitch" blue-chip opportunities I can find.

Why I Invested $28,000 Into 4 Blue-Chip Dividend Stocks

Analysts at Raymond James lowered their price target on shares of CVS Health Corp.  to $75 from $90 on Thursday, citing "the collapse in sentiment for the payor-PBM complex.

CVS stock price target lowered to $75 from $90 at Raymond James

Rite Aid

Rite Aid Corporation, CVS Health Corp and Walgreens recently announced plans to sell cannabidiol, or CBD, products in 2,500 stores across 19 states.

Retailers Signal Increased Commercial Interest In CBD

Less than a week after  BMO Capital Markets  downgraded CVS Health Corp (NYSE: CVS), Oppenheimer is stepping to the sidelines. 

Oppenheimer Joins Chorus Of CVS Analysts Cautious On Near-Term Outlook

This weekend's Barron's cover story examines the company aiming to give consumers more power over their health care.

Barron's On: CVS As The Front Door To Health Care

CVS is now the pharmacy and clinic operator at Target stores, and a deal announced this week will have Target's Shipt subsidiary delivering prescriptions from CVS across the country.

These two companies are dancing closer to each other every day.

As per our Trefis Valuation methodology, CVS Health stock is worth $62, which is about 15% higher than the current market price. Our Price Estimate is based on a P/E multiple of 10.84 and an earnings estimate of $5.80 for FY 2019.

Is CVS Health Fairly Valued?

Anadarko Petroleum

Integrated energy global giant Chevron Corporation (NYSE: CVS) said Friday it reached an agreement to acquire Anadarko Petroleum Corporation (NYSE: APC), one of the world's largest independent exploration and production companies.

Chevron To Buy Anadarko In $33B Deal

CVS Health Corp (NYSE: CVS) is trading at a discount to its historical level, rendering it attractive, but BMO Capital Markets is still wary of investing in the health care company and pharmacy chain. 

BMO: Potential Headwinds For CVS Cancel Out Valuation Advantage

Good bargains are hard to find in today's market. We have a few overlooked stocks for you to capitalize on.

Three Value Stocks that Are Absurdly Cheap Right Now

Macy's

Allergan

3 Value Stocks Are Absurdly Cheap Right Now

Cigna

Humana

The Senate Finance Committee on Tuesday grilled executives of five of the health care industry's top pharmacy benefit management companies over skyrocketing drug costs in the U.S.

Senators grill CVS Health, Cigna, Humana on rising drug costs: Time to 'get beyond the blame game'

Executives from the nation's largest pharmacy benefit managers denied that so-called "backdoor deals" with drug manufacturers are responsible for the high prices patients pay for drugs.

CVS, Cigna, Humana blame Big Pharma for high drug prices in Senate hearing

There are fundamental problems for brick-and-mortar pharmacies that the companies may be unable to solve.

News for CVS Health Stock (CVS)